Atlas Trials

A Randomized Comparison of Rifaximin Versus Lactulose in Hospitalized Cirrhotic Patients With Renal Failure

Clinical trial NCT02086825 · WITHDRAWN

Trial details

NCT number
NCT02086825
Sponsor
NYU Langone Health
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatic Encephalopathy
Start date
2015-10-01
Primary completion
2016-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.